2nd Quarter - Report

STUMPTOWN STRATEGIES for PRIME THERAPEUTICS

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Introduction to Prime to new Members of the 118th Congress Monitoring PBM Legislation Senate Finance Committee PBM Framework - Delinking S.1339 - The Pharmacy Benefit Manager Reform - Delinking H.R. 3561 - Patient Act - Transparency Requirements & Spread Pricing H.R. 4507 - Health DATA Act - Provisions related to plan fiduciaries access to data H.R.5378 - The Lower Cost More Transparency Act - Sections 105, 106, 109, 110, 202, 401, 402 & 403-provisions related to PBM transparency and disclosure

LobbyistCovered position, as disclosed
BLAIR LARKINS Staff Assistant, Greg Walden 2005-2006, Executive Assistant, Greg Walden 2006-2001

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5378 (118th), S. 1339 (118th), H.R. 4507 (118th), H.R. 3561 (118th)

Pharmacy PHA

Introduction to Prime to Members of the 118th Congress Monitoring PBM Legislation

LobbyistCovered position, as disclosed
BLAIR LARKINS Staff Assistant, Rep. Greg Walden (2005-2006); Executive Assistant, Rep. Greg Walden (2006-2011)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.